Literature DB >> 16630292

Parotid carcinoma: expression of kit protein and epidermal growth factor receptor.

Kristine Bjørndal Sørensen1, Christian Godballe, Karin de Stricker, Annelise Krogdahl.   

Abstract

OBJECTIVES: Our aim is to investigate the expression of kit protein (KIT) and epidermal growth factor receptor (EGFR) in parotid carcinomas in order to correlate the expression to histology and prognosis. Further we want to perform mutation analysis of KIT-positive adenoid cystic carcinomas. PATIENTS AND METHODS: Formalin-fixed paraffin-embedded sections from 73 patients with parotid gland carcinomas were used for the study. The sections were stained with both KIT and EGFR polyclonal antibodies. Twelve KIT-positive adenoid cystic carcinomas were examined for c-kit mutation in codon 816.
RESULTS: Of all carcinomas 25% were KIT-positive and 79% were EGFR-positive. Ninety-two percentage of the adenoid cystic carcinomas were KIT-positive. None of the adenoid cystic carcinomas had mutations in codon 816 of the c-kit gene.
CONCLUSION: Neither KIT- nor EGFR-expression seem to harbour significant prognostic information. Adenoid cystic carcinomas express KIT, but no mutations in codon 816 of the c-kit gene were identified.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16630292     DOI: 10.1111/j.1600-0714.2006.00421.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  9 in total

1.  EGFR and HER2-Akt-mTOR signaling pathways are activated in subgroups of salivary gland carcinomas.

Authors:  Shioto Suzuki; Yoh Dobashi; Hiroshi Minato; Ryosuke Tajiri; Tomokazu Yoshizaki; Akishi Ooi
Journal:  Virchows Arch       Date:  2012-07-25       Impact factor: 4.064

2.  Cell type-dependent biomarker expression in adenoid cystic carcinoma: biologic and therapeutic implications.

Authors:  Diana Bell; Dianna Roberts; Merrill Kies; Pulivarthi Rao; Randal S Weber; Adel K El-Naggar
Journal:  Cancer       Date:  2010-09-07       Impact factor: 6.860

Review 3.  Salivary gland carcinomas.

Authors:  Tobias Ettl; Stephan Schwarz-Furlan; Martin Gosau; Torsten E Reichert
Journal:  Oral Maxillofac Surg       Date:  2012-07-29

4.  Identification of c-kit gene mutations in primary adenoid cystic carcinoma of the salivary gland.

Authors:  Lizette Vila; Hongyan Liu; Samer Z Al-Quran; Dominique P Coco; Hui-Jia Dong; Chen Liu
Journal:  Mod Pathol       Date:  2009-07-17       Impact factor: 7.842

5.  [Prognostic value of immunohistochemistry in salivary gland cancer].

Authors:  T Ettl; S Schwarz; T Kühnel; P Stockmann; T E Reichert; O Driemel
Journal:  HNO       Date:  2008-02       Impact factor: 1.284

Review 6.  Adenoid cystic carcinoma: clinical and molecular features.

Authors:  Christopher A Moskaluk
Journal:  Head Neck Pathol       Date:  2013-03-05

7.  Prognostic value of expression of molecular markers in adenoid cystic cancer of the salivary glands compared with lymph node metastasis: a retrospective study.

Authors:  Seok Ki Lee; Min Su Kwon; Yoon Se Lee; Seung-Ho Choi; Sang Yoon Kim; Kyoung Ja Cho; Soon Yuhl Nam
Journal:  World J Surg Oncol       Date:  2012-12-11       Impact factor: 2.754

8.  Cystadenocarcinoma of the parotid: case report of a BRAF inhibitor treatment.

Authors:  Sabrina Boyrie; Isabelle Fauquet; Michel Rives; Caroline Genebes; Jean-Pierre Delord
Journal:  Springerplus       Date:  2013-12-18

9.  Molecularly guided treatment of metastatic parotid gland carcinoma in adults.

Authors:  Hossein Taghizadeh; Leonhard Müllauer; Robert M Mader; Thorsten Füreder; Gerald W Prager
Journal:  Wien Klin Wochenschr       Date:  2020-12-09       Impact factor: 1.704

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.